Skip to main content
Elsevier

Books in Drug adverse reactions and interactions

This portfolio explores mechanisms of adverse drug reactions, interactions, and safety monitoring. Supporting pharmacovigilance specialists, clinicians, and researchers, it features case studies, risk assessment tools, and regulatory frameworks that enhance medication safety and patient protection.

  • Meyler's Side Effects of Endocrine and Metabolic Drugs

    • 1st Edition
    • Jeffrey K. Aronson
    • English
    Elsevier now offers a series of derivative works based on the acclaimed Meylers Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing physician or health care clinician. Endocrine and metabolic diseases are common, includes diseases such as diabetes, thyroid disease, and obesity. Endocrinologists, including diabetes professionals, internal medicine and primary care practitioners, obstetricians and gynecologists, and others will find this book useful when treating endocrine or metabolic diseases.The material is drawn from the 15th edition of the internationally renowned encyclopedia, Meyler’s Side Effects of Drugs, and the latest volumes in the companion series, Side Effects of Drugs Annuals. Drug names have usually been designated by their recommended or proposed International Non-proprietary Names (rINN or pINN); when those are not available, clinical names have been used. In some cases, brand names have been used.This volume is critical for any health professional involved in the administration of endocrine and metabolics mediations.

  • Meyler's Side Effects of Psychiatric Drugs

    • 1st Edition
    • Jeffrey K. Aronson
    • English
    Elsevier now offers a series of derivative works based on the acclaimed Meylers Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing physician or health care clinician. The unwarranted effects of medications used in psychiatry can adversely affect a treatment plan. This book is critical in helping psychiatrists and mental health professionals assess the adverse effects of drugs such as antidepressants, mood stabilizers, hypnosedatives, and antipsychotic drugs.The material is drawn from the 15th edition of the internationally renowned encyclopedia, Meyler’s Side Effects of Drugs, and the latest volumes in the companion series, Side Effects of Drugs Annuals. Drug names have usually been designated by their recommended or proposed International Non-proprietary Names (rINN or pINN); when those are not available, clinical names have been used. In some cases, brand names have been used.This volume is critical for any health professional involved in the administration of psychiatric mediations.

  • Meyler's Side Effects of Herbal Medicines

    • 1st Edition
    • Jeffrey K. Aronson
    • English
    Meyler's Side Effects of Herbal Medicines, named to Doody's Core Titles for 2013, is a derivatrive work based on the acclaimed Meyler’s Side Effect of Drugs, Fifteenth Edition. This book summarizes the adverse effects of a large range of herbal medicines and the active ingredients that they contain. It includes extensive lists of the families of plants that are used as herbal medicines, including the Latin names of genera and species as well as the common names of individual plants. It features not only herbal medicines but information on important compounds such as tropane alkaloids, cardiac glycosides, nicotine, and pyrolizidine alkaloids. The book is divided into three separate sections: Family – Each monograph is organized under a family of plants (for example, Liliaceae) Genera – The various genera that are included under the family name are tabulated (for example, the family Liliaceae contains 94 genera) Species – In each monograph, some species are dealt with separately (for example, in Liliaceae, four species are included under their Latin names and major common names) Each monograph includes the following information: Alternative common names Active ingredients Uses – both traditional and modern Adverse effects References Drug names are designated by their recommended or proposed International Non-proprietary Names (rINN or pINN); when those are not available, clinical names or brand names are used. The material is drawn from the fifteenth edition of the internationally renowned encyclopedia, Meyler’s Side Effects of Drugs, and the latest volumes in the companion series, Side Effects of Drugs Annuals. This volume is critical for any health professional or homeopathic practitioner with an interest in herbal medicines.

  • Drugs During Pregnancy and Lactation

    Treatment Options and Risk Assessment
    • 2nd Edition
    • Christof Schaefer + 2 more
    • English
    The latest edition is the resource for any practicing OB/GYN, family physician, midwife, or pharmacist who prescribes medicinal products to or evaluates environmental or occupational exposures in women who are or may become pregnant. Based on the highly successful seven German editions of this reference, the up-to-date drug listings have been revised into a handy pocket guide color tabbed for quick access to important information. Easy to reference each drug is listed discussing the side effects, general impact on organ systems, potential toxicity, and risks before offering dosage recommendations. It is the only book of its kind to provide conclusive information on treatments for diseases during pregnancy and lactation and actions to be taken after (inadvertant) exposure to drugs suspected to be developmentaly toxic. Unlike other dosage guides, this edition is an affordable, compact compendium of knowledge on the very latest drugs and their effects on pregnant/lactating women.

  • Side Effects of Drugs Annual

    A Worldwide Yearly Survey of New Data and Trends in Adverse Drug Reactions
    • 1st Edition
    • Volume 28
    • Jeffrey K. Aronson
    • English
    Volume 28 in the series of Side Effects of Drugs Annuals (http://www.elsevier... continues to serve its primary goal: to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. An international team of specialists has reviewed new data and trends by selecting from the year's writing all that is truly new and informative, by critically interpreting it, and by pointing to whatever is unproven or misleading. The use of the book is enhanced by separate indexes, allowing the reader to access the text via drug name, adverse effect, or drug interaction. The current annual includes an essay by the editor, Dr Jeffrey Aronson, entitled 'Classifying Drug Adverse Reactions in the 21st Century.' In it he describes how the modern approach to classifying adverse drug reactions takes into account the dose that causes the reaction, the time-course of the reaction, and the susceptibility factors that increase the individual patient's risk, and shows how this analysis can facilitate regulatory decision making.

  • Side Effects of Drugs Annual

    A world-wide yearly survey of new data and trends in adverse drug reactions
    • 1st Edition
    • Volume 26
    • English
    The Side Effects of Drugs Annual was first published in 1977. It has been published continuously since then, as a yearly update to the encyclopaedic volume Meyler's Side Effects of Drugs. Each new Annual provides clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. An international team of specialists have contributed to the Annuals by selecting critically from each year's publications all that is truly new and informative, by critically interpreting it, and by pointing out whatever is misleading. The use of the book is enhanced by separate indexes, allowing the reader to enter the text via the drug name, adverse effect, or drug interaction.Special features of the Annuals are the Side Effects of Drugs Essay, usually written by a guest author, and the special reviews: short articles, within the different chapters, that give extra attention to topics of current interest.The Essay in Annual 26 is entitled 'How safe is cannabis?' (by Professor L.L. Iversen) and there is a Historical Essay entitled 'From thalidomide to pharmacovigilance: a personal account' (by Professor D.J. Finney).The special reviews in this volume include, among others: The cognitive effects of Ecstasy Antipsychotic drugs and weight gain Vigabatrin-related visual abnormalities Managing the adverse effects of morphine The cardiotoxic effects of antihistamines Inhaled corticosteroids and growth inhibition in children Bioterrorism and its prevention through immunization

  • Side Effects of Drugs Annual

    A World-Wide Survey of New Data and Trends in Adverse Drug Reactions
    • 1st Edition
    • Volume 25
    • English
    Volume 25 in the series http://www.elsevier.... Effects of Drugs Annuals continues to serve the goal that is set for it: to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. An international team of specialists has reviewed new data and trends by selecting from the year's writing all that is truly new and informative, by critically interpreting it, and by pointing to whatever is misleading. Special features of the current annual are an essay by Dr Lara Marks, entitled 'The pill: untangling the adverse effects of a drug', invaluable for all workers in the field of Women's health and birth control, and a review of the adverse effects of Anthracycline Antibiotics by Dr Fraser and Dr Twelves, published as part of the chapter on 'Cytostatics' by Dr Andrew Stanley. Other important features of this Annual are the many special reviews. An index of Special Reviews is published in the book. The special reviews are short articles that deal in depth with a specific topic of current interest, typographically distinguished from the rest of the text, and marked by the prescription symbol of the eye of Horus. The current Annual is enriched with the infamous 'Drug Index' and 'Index of Adverse Drug Reactions'.Side Effects of Drugs Annual 25 is the second update of the encyclopaedic volume http://www.elsevier.... Side Effects of Drugs, Fourteenth Edition, which was published in 2000.

  • Side Effects of Drugs Annual

    • 1st Edition
    • Volume 24
    • English
    The Side Effects of Drugs Annual is designed to provide a critical and up-to-date account of new information related to adverse drug reactions and interactions from the clinician's point of view. Under the supervision of the series editors, an international team of expert authors have gathered together the latest information on adverse drug effects from the international literature. In addition to describing new reports of adverse drug effects, the authors have subjected those reports to critical analysis, setting them into context in terms of clinical relevance and importance, and cross-referring to previous reports where necessary. New adverse effects are reported and evaluated and previously reported adverse effects are re-evaluated in the light of the most recent information. A special feature is the reviews, in which selected adverse effects are discussed in depth. The use of the book is enhanced by two separate indexes, allowing the reader to enter the text by drug name, adverse effect name, or drug interaction. The current Annual is the first update of the standard encyclopaedic work in this field, http://www.elsevier.... Side Effects of Drugs, Fourteenth Edition, which was published in December 2000.

  • Side Effects of Drugs Annual

    • 1st Edition
    • Volume 20
    • English
    The Side Effects of Drugs Annual has been published each year since 1977. It is designed to provide a critical and up-to-date account of new information related to adverse drug reactions and interactions from the clinician's point of view.Under the supervision of the series editors, an international team of expert authors have gathered together the latest information on adverse drug effects from the international literature. In addition to describing new reports of adverse drug effects, the authors have subjected those reports to critical analysis, setting them into context in terms of clinical relevance and importance, and cross-referring to previous reports where necessary. New adverse effects are reported and evaluated and previously reported adverse effects are re-evaluated in the light of the most recent information. A special feature is the reviews, in which selected adverse effects are discussed in depth. The use of the book is enhanced by two separate indexes, allowing the reader to enter the text by drug name, adverse effect name, or drug interaction.The Annual can be used independently or as a supplement to the standard encyclopaedic work in this field, Meyler's Side Effects of Drugs, of which, the http://www.elsevier.... Edition was published in December 2000.

  • A Manual of Adverse Drug Interactions

    • 5th Edition
    • J.P. Griffin + 1 more
    • English
    For twenty years this book, now in its 5th edition, has provided information on adverse drug interactions that is unrivalled in coverage and scholarship.Adverse drug reactions, many of them ascribable to interactions with other drugs or with chemical substances in food or the environment, are thought to cause or complicate one in twenty of hospital admissions.The book is conveniently divided into two parts: Part 1 comments on drug interactions and their mechanisms, on a pharmacokinetic and pharmacodynamic level, while Part 2 consists of drug interaction tables, divided and subdivided into categories of disorders, and the drugs used in the treatment of these disorders.If safety in drugs is to improve, education of prescribers is vitally important. This book, with its up-to-date and coordinated approach, serves that purpose well. The real threat, as the authors remind us, is the ignorance of practitioners, not the drug itself. The volume is therefore an essential addition to the shelves of those responsible for the prescription of drugs, in order to prevent a potential backlash when used in combination with other drugs or chemical substances.